Showing results (911-920 of 9,976) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|April 5, 2017
FcγRIIb expression in early stage chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Eva Puy Vicente, et al.Leukemia & Lymphoma|March 11, 2014
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experienceXiao-xiao Wang, Hui-qiang Huang, Bing Bai, et al.Leukemia & Lymphoma|January 30, 2014
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosisMarco Chilosi, Fabio Facchetti, Anna Caliò, et al.Leukemia & Lymphoma|September 29, 2016
The significance of FOXP1 in diffuse large B-cell lymphomaDuncan M Gascoyne, Alison H BanhamLeukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.Leukemia & Lymphoma|April 11, 2017
A novel recurrent copy number loss region on 6q23.3 in MDS-related myeloid malignancy patients with stable survival conditionsKun Chi, Yang Li, Lan Xu, et al.Leukemia & Lymphoma|April 12, 2017
WT1 protein is cleaved by caspase-3 in apoptotic leukemic cellsJichen Ruan, Shenmeng Gao, Junjun Yang, et al.Leukemia & Lymphoma|April 2, 2014
Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemiaNashwa Khairat Abousamra, Manal Salah El-Din, Eman Hamza Elzahaf, et al.Leukemia & Lymphoma|April 3, 2014
Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in EgyptRabab M Aly, Mona M Taalab, Hayam F GhazyLeukemia & Lymphoma|April 10, 2014
The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?Joshua F Zeidner, Marianna Zahurak, Gary L Rosner, et al.Pageof 998